DOCMF Financial Statements From 2010 to 2024
| DOCMF Stock | USD 0.72 0.02 2.86% |
Check Dr Martens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Martens' main balance sheet or income statement drivers, such as , as well as many indicators such as . DOCMF financial statements analysis is a perfect complement when working with Dr Martens Valuation or Volatility modules.
DOCMF |
Dr Martens plc Company Operating Margin Analysis
Dr Martens' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Dr Martens Operating Margin | 0.23 % |
Most of Dr Martens' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Martens plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Dr Martens plc has an Operating Margin of 0.2309%. This is 96.39% lower than that of the Consumer Cyclical sector and 97.76% lower than that of the Footwear & Accessories industry. The operating margin for all United States stocks is 104.19% lower than that of the firm.
Dr Martens plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Martens's current stock value. Our valuation model uses many indicators to compare Dr Martens value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Martens competition to find correlations between indicators driving Dr Martens's intrinsic value. More Info.Dr Martens plc is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Dr Martens plc is roughly 3.94 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Martens' earnings, one of the primary drivers of an investment's value.About Dr Martens Financial Statements
Dr Martens stakeholders use historical fundamental indicators, such as Dr Martens' revenue or net income, to determine how well the company is positioned to perform in the future. Although Dr Martens investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dr Martens' assets and liabilities are reflected in the revenues and expenses on Dr Martens' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dr Martens plc. Please read more on our technical analysis and fundamental analysis pages.
Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Martens plc was founded in 1945 and is based in London, the United Kingdom. DR MARTENS operates under Footwear Accessories classification in the United States and is traded on OTC Exchange. It employs 2229 people.
Currently Active Assets on Macroaxis
Other Information on Investing in DOCMF Pink Sheet
Dr Martens financial ratios help investors to determine whether DOCMF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCMF with respect to the benefits of owning Dr Martens security.